Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1969 Mar 31;129(4):605–622. doi: 10.1084/jem.129.4.605

DISSOCIATION OF HEMOLYTIC AND LYMPHOCYTE-TRANSFORMING ACTIVITIES OF STREPTOLYSIN S PREPARATIONS

Angelo Taranta 1, Girolamo Cuppari 1, Franco Quagliata 1
PMCID: PMC2138631  PMID: 4387992

Abstract

The ability of streptolysin S preparations to induce high percentages of transformation in human peripheral blood lymphocytes was confirmed in a series of apparently healthy donors. Transforming activity was not demonstrated in the two media used for streptolysin S production, nor in control preparations in which a strain each of Streptococcus viridans, Staphylococcus aureus (nonhemolytic), and Diplococcus pneumoniae was substituted for the beta hemolytic streptococcal strain used for streptolysin S production. The relation of the hemolytic activity to the lymphocyte transforming activity of streptolysin S preparations was studied by means of inactivation and fractionation experiments. Heating produced a loss in both activities, but more in the hemolytic than in the transforming activity. The transformation obtained with a heated preparation had a high degree of correlation with that obtained with the unheated preparation in a series of normal subjects and patients with various rheumatic diseases, whose lymphocytes were often less responsive to stimulation with streptolysin S preparations (both heated and unheated) than the lymphocytes of the normal subjects studied. Treatment of streptolysin S preparations with chymotrypsin, vegetable lecithin, or trypan blue (the latter in minute amounts) resulted in preparations with no detectable hemolytic activity but with undiminished lymphocyte transforming activity. Chromatographic fractionations on DEAE-Sephadex columns yielded fractions endowed with transforming but not with hemolytic activity, and other fractions endowed with hemolytic but not with transforming activity. The recovery of the hemolytic activity was not complete and quantitation of the recovery of the transforming activity was not attempted. These experiments indicate that the hemolytic and transforming activities of streptolysin S preparations are independent of each other, and specifically that they are the attributes of two different streptococcal products, one of which is streptolysin S. The other is a nonhemolytic streptococcal product present in streptolysin S preparations but previously unrecognized. Some implications of these findings are discussed.

Full Text

The Full Text of this article is available as a PDF (1,020.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BACH F., HIRSCHHORN K. LYMPHOCYTE INTERACTION: A POTENTIAL HISTOCOMPATIBILITY TEST IN VITRO. Science. 1964 Feb 21;143(3608):813–814. doi: 10.1126/science.143.3608.813. [DOI] [PubMed] [Google Scholar]
  2. BERNHEIMER A. W., RODBART M. The effect of nucleic acids and of carbohydrates on the formation of streptolysin. J Exp Med. 1948 Aug;88(2):149–168. doi: 10.1084/jem.88.2.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BERNHEIMER A. W. Stabilization of streptolysin S by potassium ions. J Exp Med. 1950 Aug;92(2):129–132. doi: 10.1084/jem.92.2.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bernheimer A. W. Cytolytic toxins of bacterial origin. The nature and properties of cytolytic proteins are discussed with emphasis on staphylococcal alpha-toxin. Science. 1968 Feb 23;159(3817):847–851. doi: 10.1126/science.159.3817.847. [DOI] [PubMed] [Google Scholar]
  5. Caron G. A., Sarkany I., Williams H. S., Todd A. P., Gell H. M. Radioactive method for the measurement of lymphocyte transformation in vitrol. Lancet. 1965 Dec 18;2(7425):1266–1268. doi: 10.1016/s0140-6736(65)92282-8. [DOI] [PubMed] [Google Scholar]
  6. Chessin L. N., Börjeson J., Welsh P. D., Douglas S. D., Cooper H. L. Studies on human peripheral blood lymphocytes in vitro. II. Morphological and biochemical studies on the transformation of lymphocytes by pokeweed mitogen. J Exp Med. 1966 Nov 1;124(5):873–884. doi: 10.1084/jem.124.5.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DUTTON R. W., EADY J. D. AN IN VITRO SYSTEM FOR THE STUDY OF THE MECHANISM OF ANTIGENIC STIMULATION IN THE SECONDARY RESPONSE. Immunology. 1964 Jan;7:40–53. [PMC free article] [PubMed] [Google Scholar]
  8. Edelman R., Wheelock E. F. Specific role of each human leukocyte type in viral infections. I. Monocyte as host cell for vesicular stomatitis virus replication in vitro. J Virol. 1967 Dec;1(6):1139–1149. doi: 10.1128/jvi.1.6.1139-1149.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Elves M. W. Suppression of antibody production by phytohaemagglutinin. Nature. 1967 Feb 4;213(5075):495–496. doi: 10.1038/213495a0. [DOI] [PubMed] [Google Scholar]
  10. FARNES P., BARKER B. E., BROWNHILL L. E., FANGER H. MITOGENIC ACTIVITY IN PHYTOLACCA AMERICANA (POKEWEED). Lancet. 1964 Nov 21;2(7369):1100–1101. doi: 10.1016/s0140-6736(64)92616-9. [DOI] [PubMed] [Google Scholar]
  11. Friedman R. M., Cooper H. L. Stimulation of interferon production in human lymphocytes by mitogens. Proc Soc Exp Biol Med. 1967 Jul;125(3):901–905. doi: 10.3181/00379727-125-32235. [DOI] [PubMed] [Google Scholar]
  12. GINSBURG I., BENTWICH Z. EFFECT OF CYSTEINE ON FORMATION OF STREPTOLYSIN S BY GROUP A STREPTOCOCCI. Proc Soc Exp Biol Med. 1964 Dec;117:670–675. doi: 10.3181/00379727-117-29664. [DOI] [PubMed] [Google Scholar]
  13. GINSBURG I., BENTWICH Z., HARRIS T. N. OXYGEN-STABLE HEMOLYSINS OF GROUP A STREPTOCOCCI. 3. THE RELATIONSHIP OF THE CELL-BOUND HOMOLYSIN TO STREPTOLYSIN S. J Exp Med. 1965 Apr 1;121:633–645. doi: 10.1084/jem.121.4.633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. GINSBURG I., HARRIS T. N. OXYGEN-STABLE HEMOLYSINS OF BETA-HEMOLYTIC STREPTOCOCCI. Ergeb Mikrobiol Immunitatsforsch Exp Ther. 1964;38:198–222. doi: 10.1007/978-3-662-42622-7_6. [DOI] [PubMed] [Google Scholar]
  15. HIRSCHHORN K., SCHREIBMAN R. R., VERBO S., GRUSKIN R. H. THE ACTION OF STREPTOLYSIN S ON PERIPHERAL LYMPHOCYTES OF NORMAL SUBJECTS AND PATIENTS WITH ACUTE RHEUMATIC FEVER. Proc Natl Acad Sci U S A. 1964 Nov;52:1151–1157. doi: 10.1073/pnas.52.5.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. HUMPHREY J. H. The nature of antistreptolysin S in the sera of man and of other species; antistreptolysin titres in normal and diseased states. Br J Exp Pathol. 1949 Aug;30(4):345–351. [PMC free article] [PubMed] [Google Scholar]
  17. Hanna E. E., Watson D. W. Host-parasite relationships among group A streptococci. IV. Suppression of antibody response by streptococcal pyrogenic exotoxin. J Bacteriol. 1968 Jan;95(1):14–21. doi: 10.1128/jb.95.1.14-21.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. LING N. R., SPICER E., JAMES K., WILLIAMSON N. THE ACTIVATION OF HUMAN PERIPHERAL LYMPHOCYTES BY PRODUCTS OF STAPHYLOCOCCI. Br J Haematol. 1965 Jul;11:421–431. doi: 10.1111/j.1365-2141.1965.tb06604.x. [DOI] [PubMed] [Google Scholar]
  19. MCCARTY M. MISSING LINKS IN THE STREPTOCOCCAL CHAIN LEADING TO RHEUMATIC FEVER. Circulation. 1964 Apr;29:SUPPL–SUPPL:493. doi: 10.1161/01.cir.29.4.488. [DOI] [PubMed] [Google Scholar]
  20. Malakian A., Schwab J. H. Immunosuppressant from group A streptococci. Science. 1968 Feb 23;159(3817):880–881. doi: 10.1126/science.159.3817.880. [DOI] [PubMed] [Google Scholar]
  21. Merigan T. C., Jr Interferon's promise in clinical medicine. Fact or fancy? Am J Med. 1967 Dec;43(6):817–821. doi: 10.1016/0002-9343(67)90240-9. [DOI] [PubMed] [Google Scholar]
  22. Oppenheim J. J. Relationship of in vitro lymphocyte transformation to delayed hypersensitivity in guinea pigs and man. Fed Proc. 1968 Jan-Feb;27(1):21–28. [PubMed] [Google Scholar]
  23. Perlmann P., Perlmann H., Holm G. Cytotoxic action of stimulated lymphocytes on allogenic and autologous erythrocytes. Science. 1968 Apr 19;160(3825):306–309. doi: 10.1126/science.160.3825.306. [DOI] [PubMed] [Google Scholar]
  24. STOLLERMAN G. H., BERNHEIMER A. W. Inhibition of streptolysin S by the serum of patients with rheumatic fever and acute streptococcal pharyngitis. J Clin Invest. 1950 Sep;29(9):1147–1155. doi: 10.1172/JCI102352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Starzl T. E., Marchioro T. L., Porter K. A., Iwasaki Y., Cerilli G. J. The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet. 1967 Feb;124(2):301–308. [PMC free article] [PubMed] [Google Scholar]
  26. Taranta A., Cuppari G., Quagliata F. High lymphocyte transformation with non-haemolytic streptococcal product. Nature. 1968 Aug 17;219(5155):757–758. doi: 10.1038/219757a0. [DOI] [PubMed] [Google Scholar]
  27. WOODRUFF M. F., ANDERSON N. A. EFFECT OF LYMPHOCYTE DEPLETION BY THORACIC DUCT FISTULA AND ADMINISTRATION OF ANTILYMPHOCYTIC SERUM ON THE SURVIVAL OF SKIN HOMOGRAFTS IN RATS. Nature. 1963 Nov 16;200:702–702. doi: 10.1038/200702a0. [DOI] [PubMed] [Google Scholar]
  28. Wheelock E. F. Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science. 1965 Jul 16;149(3681):310–311. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES